Pharmacovigilance, also known as drug safety, encompasses activities relating to the detection, assessment, understanding, and prevention of adverse effects.Read more
A Real-World Study from Amgen® and Veradigm®: Early Use of Erenumab in US Clinical Practice was associated with high adherence and reductions in medications.Read more
Qualitative Analysis of Provider Notes on Atopic Dermatitis-Related Visits Using Natural Language Processing Methods: Real-World Study from Eli Lilly & VeradigmRead more
This real-word study from Veradigm® and Seqirus™ examined the relative effectiveness of cell culture-derived and egg-derived quadrivalent influenza vaccines.Read more
Obtaining and analyzing social determinant of health (SDoH) data relevant to a particular research question can be extremely challenging. Read our latest eBook.Read more
Real-World Use of IDegLira in US Clinical Practice: A Safety and Effectiveness Study from the Medical College of Wisconsin, Novo Nordisk, and Veradigm®Read more
Real-World Practice Study by AstraZeneca and Veradigm Details Clinical Characteristics and Healthcare Resource Use in COPD Patients treated with LAMA and LABA.Read more
Real-world complexity of NAFLD and NASH: identifying and addressing gaps in diagnosis and disease management.Read more
Retrospective US cohort study conducted by AstraZeneca and Veradigm links blood eosinophil count to clinical and economic burden in patients with COPD.Read more
A recent real-world study with a retrospective cohort analysis into care gaps and fracture risk in patients with osteopenia and osteoporosis.Read more
This whitepaper reviews the management and pharmacologic treatment of moderate-to-severe asthma & an eosinophilic asthma subtype with a retrospective cohort analysis using a Veradigm EHR.Read more
This paper summarizes the challenges associated with concordant comorbidities in individuals living with type 2 diabetes and further explores how real-world evidence and natural language processing may be used to offer insight regarding opportunities for management.Read more
A retrospective data analysis using de-identified patient data may provide insights regarding HFpEF (Heart Failure with Preserved Ejection Fraction) and improve the quality of life.Read more
Read how Veradigm™ leverages Systolic Heart Failure Real-World Evidence in a Case Study using Electronic Health Records.Read more
The 2019 Physician Fee Schedule Final Rule was released on November 1, 2018 by the Centers for Medicare and Medicaid Services (CMS).Read more
On December 7, 2018, the FDA released the Framework for FDA’s Real World Evidence program, and the regulatory team at Veradigm has provided a brief overview below, including information from the report related to definitions, usability, and stakeholder involvement.Read more
Veradigm’s Data Enrichment Service leverages data enrichment capabilities to enhance capture and extraction of structured facts from an ambulatory patient EHR.Read more
Hello! Which of these are you interested in?
Which Biopharma and Device products are you interested in?
Which Health Plans and Payers products are you interested in?
Which Healthcare Providers products are you interested in?
Which Health IT Partners products are you interested in?
It looks like you're interested in Real-World Evidence. Please provide some final details: